Medtronic
Medtronic plc (NYSE: MDT) is the leading global healthcare technology company, headquartered in Ireland and serving healthcare systems, physicians, clinicians, and patients in more than 150 countries worldwide. Founded in 1949, the company operates with a mission to alleviate pain, restore health, and extend life… From the company’s description.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Medtronic does
In the company’s own words
Medtronic plc (NYSE: MDT) is the leading global healthcare technology company, headquartered in Ireland and serving healthcare systems, physicians, clinicians, and patients in more than 150 countries worldwide. Founded in 1949, the company operates with a mission to alleviate pain, restore health, and extend life through the application of biomedical engineering. More information about the company is available at www.medtronic.com.
The company operates three primary reportable segments: the Cardiovascular Portfolio, the Neuroscience Portfolio, and the Medical Surgical Portfolio. The Cardiovascular Portfolio encompasses cardiac rhythm management, structural heart and aortic therapies, and coronary and peripheral vascular solutions. The Neuroscience Portfolio includes cranial and spinal technologies, specialty therapies for stroke and neurological conditions, and neuromodulation systems for chronic pain and brain modulation. The Medical Surgical Portfolio comprises surgical and endoscopy products alongside acute care and monitoring solutions. In March 2026, Medtronic completed the initial public offering of its Diabetes Business, which was separated as MiniMed Group, Inc.
Medtronic employs over 95,000 full-time employees globally, with 43 percent based in the United States or Puerto Rico. The company manufactures products at facilities located throughout the world and maintains a global distribution network combining direct sales representatives and third-party distributors.
The company's product portfolio includes implantable cardiac devices, surgical instruments, robotic-assisted surgery systems, neurovascular products, spinal implants, and patient monitoring systems. Notable brands and technologies include the Azure pacemaker line, CoreValve aortic valve systems, Hugo robotic-assisted surgery platform, Evolut transcatheter aortic valve replacement systems, and various neuromodulation and spinal cord stimulation devices.
Medtronic's competitive advantages include extensive intellectual property protections, established relationships with healthcare providers and institutions, advanced manufacturing capabilities, and a robust research and development pipeline addressing unmet clinical needs. The company pursues innovation through internal development, strategic acquisitions, licensing arrangements, and external collaborations to maintain technological leadership across its diverse therapeutic markets.
Company details
- Sector
- Health Care
- Industry (SIC)
- Electromedical Apparatus
- Headquarters
- GALWAY
- Fiscal year end
- April
- CIK
- 1613103
- SIC
- 3845
Financial performance, year by year
Fiscal 2015–2026 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Medtronic — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Superinvestors in Medtronic · what they did last quarter
Share of each manager’s reported 13F portfolio. Change is in shares held, since the previous quarter.
Largest fund holders · Medtronic’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Fund ownership is a subset of institutional 13F ownership — the two describe overlapping populations and must not be added together.
Could not be determined for this company: bond issues.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Medtronic and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Medtronic's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Medtronic's last four quarterly filings that the numbers alone won't show?”